Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001214659-23-012639
Filing Date
2023-09-26
Accepted
2023-09-26 11:06:10
Documents
2
Group Members
KEVIN TANGTANG CAPITAL MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 x926230sc13g.htm SC 13G 84259
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 7747
  Complete submission text file 0001214659-23-012639.txt   93583
Mailing Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121 858-200-3830
TANG CAPITAL PARTNERS LP (Filed by) CIK: 0001191935 (see all company filings)

EIN.: 680517277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Subject) CIK: 0001829635 (see all company filings)

EIN.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92695 | Film No.: 231278234
SIC: 2834 Pharmaceutical Preparations